Researchers at Peking Union Medical College Hospital have mapped out why pairing two well-known cancer drugs can turn “sleepy” immune cells back into tumor killers. In a new Perspective published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback